| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.083 | 0.6 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.6 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |